Skip to main content
Premium Trial:

Request an Annual Quote

Protedyne to Use $12M VC Infusion to Bolster Staff, Ramp Development

NEW YORK, Nov. 1 – A recent $12 million private equity infusion has spurred Protedyne to expand its manufacturing operations and hire on 30 new staff, the company said on Thursday.

Protedyne, based in Windsor, Conn., said that the capital also will be used to help the research-automation firm bolster its new BioCube and BioResearch products.

The new positions, which will be brought on during the next three months, will include proteomic and genomic research, manufacturing, mechanical, and electrical design, field service, machine assembly, marketing, and software development, Protedyne said in a statement.

"Since we launched our first products early this year, we have established strong relationships with the leading genomic and drug discovery firms," Stan Klein, president of Protedyne, said. "This expansion will allow us to extend our reach in the marketplace and meet our customers' urgent demand to accelerate the discovery process."

As GenomeWeb reported , Protedyne on Oct. 12 had closed $12 million in a Series B financing round. 

The investment comes just eight business days after Protedyne secured $850,000 in Series A financing, a spokesman for the company said.

The Scan

Study Finds Sorghum Genetic Loci Influencing Composition, Function of Human Gut Microbes

Focusing on microbes found in the human gut microbiome, researchers in Nature Communications identified 10 sorghum loci that appear to influence the microbial taxa or microbial metabolite features.

Treatment Costs May Not Coincide With R&D Investment, Study Suggests

Researchers in JAMA Network Open did not find an association between ultimate treatment costs and investments in a drug when they analyzed available data on 60 approved drugs.

Sleep-Related Variants Show Low Penetrance in Large Population Analysis

A limited number of variants had documented sleep effects in an investigation in PLOS Genetics of 10 genes with reported sleep ties in nearly 192,000 participants in four population studies.

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.